Literature DB >> 15259425

Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings.

Andrew W Campbell1, Jack D Thrasher, Roberta A Madison, Aristo Vojdani, Michael R Gray, Al Johnson.   

Abstract

Adverse health effects of fungal bioaerosols on occupants of water-damaged homes and other buildings have been reported. Recently, it has been suggested that mold exposure causes neurological injury. The authors investigated neurological antibodies and neurophysiological abnormalities in patients exposed to molds at home who developed symptoms of peripheral neuropathy (i.e., numbness, tingling, tremors, and muscle weakness in the extremities). Serum samples were collected and analyzed with the enzyme-linked immunosorbent assay (ELISA) technique for antibodies to myelin basic protein, myelin-associated glycoprotein, ganglioside GM1, sulfatide, myelin oligodendrocyte glycoprotein, alpha-B-crystallin, chondroitin sulfate, tubulin, and neurofilament. Antibodies to molds and mycotoxins were also determined with ELISA, as reported previously. Neurophysiologic evaluations for latency, amplitude, and velocity were performed on 4 motor nerves (median, ulnar, peroneal, and tibial), and for latency and amplitude on 3 sensory nerves (median, ulnar, and sural). Patients with documented, measured exposure to molds had elevated titers of antibodies (immunoglobulin [Ig]A, IgM, and IgG) to neural-specific antigens. Nerve conduction studies revealed 4 patient groupings: (1) mixed sensory-motor polyneuropathy (n = 55, abnormal), (2) motor neuropathy (n = 17, abnormal), (3) sensory neuropathy (n = 27, abnormal), and (4) those with symptoms but no neurophysiological abnormalities (n = 20, normal controls). All groups showed significantly increased autoantibody titers for all isotypes (IgA, IgM, and IgG) of antibodies to neural antigens when compared with 500 healthy controls. Groups 1 through 3 also exhibited abnormal neurophysiologic findings. The authors concluded that exposure to molds in water-damaged buildings increased the risk for development of neural autoantibodies, peripheral neuropathy, and neurophysiologic abnormalities in exposed individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15259425     DOI: 10.3200/AEOH.58.8.464-474

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  8 in total

1.  Mycotoxins in indoor environments.

Authors:  H M Ammann
Journal:  Mycotoxin Res       Date:  2005-09       Impact factor: 3.833

Review 2.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

3.  Non-Thyroidal Illness Syndrome in Patients Exposed to Indoor Air Dampness Microbiota Treated Successfully with Triiodothyronine.

Authors:  Taija Liisa Somppi
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

Review 4.  Clinical Diagnosis of the Dampness and Mold Hypersensitivity Syndrome: Review of the Literature and Suggested Diagnostic Criteria.

Authors:  Ville Valtonen
Journal:  Front Immunol       Date:  2017-08-10       Impact factor: 7.561

5.  Clinical and allergological analysis of ocular manifestations of sick building syndrome.

Authors:  Yusuke Saeki; Kazuaki Kadonosono; Eiichi Uchio
Journal:  Clin Ophthalmol       Date:  2017-03-14

Review 6.  Mold, Mycotoxins and a Dysregulated Immune System: A Combination of Concern?

Authors:  Stephanie Kraft; Lisa Buchenauer; Tobias Polte
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

7.  A Novel Link between Early Life Allergen Exposure and Neuroimmune Development in Children.

Authors:  Nataliya M Kushnir-Sukhov
Journal:  J Clin Exp Immunol       Date:  2020-08-05

Review 8.  Multiple Chemical Sensitivity.

Authors:  Gesualdo M Zucco; Richard L Doty
Journal:  Brain Sci       Date:  2021-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.